Loading...

Gilead Sciences, Inc.

GILD•NASDAQ
HealthcareDrug Manufacturers - General
$110.08
$-1.03(-0.93%)

Gilead Sciences, Inc. (GILD) AI-Powered Stock Analysis

See how Gilead Sciences, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Gilead Sciences, Inc. (GILD) Stock Overall Grade

Gilead Sciences, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Gilead Sciences, Inc.'s overall stock rating.

Forecast

A+

Score

97/100

Financial Growth

C+

Score

55/100

Fundamental Growth

B+

Score

79/100

Key Ratios

B

Score

67/100

Sector Comparison

B+

Score

75/100

Industry Comparison

A+

Score

90/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

B+

Score

71/100

Component Analysis Explained

Understand the key factors behind each Gilead Sciences, Inc. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions